DeutschNewstral
Article
bizjournals.com on 2015-08-25 20:28
Biotech bounces back: A roundup of the Bay State’s public drugmakers
Related news
- BBJ Live: What you may have missed in recent Bay State biotech news (Video)bizjournals.com
- Waltham-based Eyegate holds state’s smallest biotech IPO since 2013bizjournals.com
- Bay State’s newest Nasdaq-listed biotech, Corbus gets $5M cystic fibrosis grantbizjournals.com
- Three Bay State biotechs that bucked the recent sell-off — and whybizjournals.com
Drugmakers investing in biotech companiesnwaonline.com- Alnylam to move HQ to former Vertex site in big 2018 biotech shufflebizjournals.com
- Seres raises $133M in state’s second-biggest biotech IPO in yearsbizjournals.com
- Short-seller who targeted Beverly biotech takes aim at Ocatabizjournals.com
- Five Bay State biotech firms investors love to hatebizjournals.com
- OPortland-based biotech firm completes move to Bay Areaoregonbusiness.com
- Top two executives at embattled Cambridge biotech Aegerion resignbizjournals.com
- California biotech to pay Bay State $1.3M over alleged false marketingbizjournals.com
- NExplore Bay State’s skeletons beneath Old North Churchnorthendregionalreview.com
- TExplore the Bay State’s skeletons beneath Old North Churchthebostonsun.com
- CExplore the Bay State’s Skeletons Beneath Old North Churchcharlestownbridge.com
- Cambridge biotech to lease nearly half of new HQ to IBMbizjournals.com
- The Funded: This week's 2 biotech IPOs top Monday's Bay Area VC-backed deal roundupbizjournals.com
- How the 10 biggest Bay State biotech IPOs since 2013 have performed (BBJ photo gallery)bizjournals.com